Zobrazeno 1 - 10
of 18
pro vyhledávání: '"J M, Bonfrer"'
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 28(2)
Our purpose was to determine whether S-100B or melanoma inhibitory activity (MIA) concentrations in the serum of patients with large uveal melanomas were better markers for the presentation of metastases than liver function tests. We also investigate
Autor:
J M, Bonfrer, C M, Korse
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 158
To assess the usefulness of the S-100B tumour marker in monitoring therapy and during follow-up we measured S-100B serum concentration in 31 patients participating in a phase I trial studying the effect of vaccination with GM-CSF gene-transduced auto
Autor:
P, Toniolo, P F, Bruning, A, Akhmedkhanov, J M, Bonfrer, K L, Koenig, A, Lukanova, R E, Shore, A, Zeleniuch-Jacquotte
Publikováno v:
International journal of cancer. 88(5)
Insulin-like growth factor I (IGF-I) is a systemic hormone with potent mitogenic and anti-apoptotic properties, which could influence the proliferative behavior of normal breast cells. Limited epidemiological observations suggest that the hormone may
Autor:
J M, Klaase, J C, Swaanenburg, H, Schouwink, M N, Sosef, J M, Bonfrer, F A, Zoetmulder, E J, Rutgers, P, Baas
Publikováno v:
Photochemistry and photobiology. 71(3)
In five patients who were treated for malignant pleural mesothelioma (MPM) with pleuropneumonectomy and intraoperative photodynamic therapy (IPDT), impending myocardial damage was monitored using ECG, the classical biochemical markers (creatine kinas
Publikováno v:
Anticancer research. 17(4B)
Serum concentrations of CEA and Cyfra were compared in patients with mesothelioma.Serum levels of patients were analysed for prognosis of survival and follow up of disease.Cyfra 21-1 and TPA have significant prognostic value for survival.Assays measu
Publikováno v:
Anticancer research. 17(4B)
Pretreatment serum values of S-100 and NSE were compared in patients with malignant melanoma.Pretreatment serum levels of patients with malignant melanoma were analysed for stage of disease and survival.S-100 pretreatment serum values seem highly spe
Publikováno v:
Clinical chemistry. 43(3)
The Byk LIA-mat CA125 II assay was compared with the Centocor IRMA CA125 II. Serum samples studied (n = 1012) were obtained from 652 apparently healthy females, 61 pregnant women, and 299 patients with benign and malignant gynecological tumors. The C
Publikováno v:
Cancer. 78(1)
Changes in serum CA 125 from baseline do not reflect response to paclitaxel in relapsed ovarian carcinoma patients. Our study aimed to determine whether CA 125 changes relate to tumor response and overall survival during paclitaxel salvage treatment.
Autor:
K N, Gaarenstroom, J M, Bonfrer, G G, Kenter, C M, Korse, A A, Hart, J B, Trimbos, T J, Helmerhorst
Publikováno v:
Cancer. 76(5)
The clinical value of pretreatment serum concentrations of cytokeratin 19 fragments, measured by Cyfra 21-1, was compared with tissue polypeptide antigen (TPA) and squamous cell carcinoma antigen (SCC-Ag) in 78 patients with squamous cell cervical ca
Autor:
K N, Gaarenstroom, G G, Kenter, J M, Bonfrer, C M, Korse, M P, Gallee, A A, Hart, M, Müller, J B, Trimbos, T J, Helmerhorst
Publikováno v:
Cancer. 74(8)
The objective of this study was to investigate the prognostic significance of serum antibodies to human papillomavirus (HPV)-16 peptides in patients with squamous cell cervical cancer.Pretreatment sera from 78 patients and 198 control women were test